MedCity News January 22, 2024
Ron Harman King

No matter the outcome, it’s certain that the cost of drugs will not be an issue easily resolved anytime soon even though several other states also have laws allowing for drug imports.

On January 5, the U.S. Food and Drug Administration (FDA) authorized the state of Florida to import medications from Canada in a measure to lower prices for the state’s residents. To no one’s surprise, the pharmaceutical industry has greeted the news as though it were another sub-zero arctic blast sweeping down from the Canadian prairies.

The American Society of Health-System Pharmacists (ASHSP) labeled the effort futile, saying that the “Canadian market cannot supply anywhere close to the amount of medication needed to bring down U.S. drug prices.”

Further,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
STAT+: Minnesota becomes first state to release report on 340B drug discount program for ‘safety-net’ hospitals
California Sets 15% Goal for Primary Care Spending by 2034
5 objectives for achieving high-quality primary care at the state level
State Reported Efforts to Address Health Disparities: A 50 State Review
How much each state has spent to expand Medicaid

Share This Article